Medical devices, healthcare technology and the business of care
510(k) clearance · K260226

ElintMAX Respiratory Monitor (ElintMAX Monitor A1)

Amptron Medical, Inc. · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONK260226

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-16 for K260226, submitted by Amptron Medical, Inc. of Carlsbad, California, for the ElintMAX Respiratory Monitor (ElintMAX Monitor A1). The device falls under regulation 868.1850, classification product code BZK, with subsequent product code BZQ, and the regulation medical specialty and 510(k) review panel are both anesthesiology. The submission was a traditional 510(k) received on 01/26/2026, not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. SESE means clearance to market, not PMA approval.

The public record does not describe the device's components, its specific indications for use, or the predicate device relied upon, and no summary statement is present in the retrieved data. The TPLC listing associates Amptron Medical with regulation 868.1850 and the K260226 record, but its excerpts are fragmentary and do not add substantive detail about the cleared device. Any comparison to another cleared respiratory monitor, or any claim about clinical performance, would require the underlying FDA documents rather than this database entry.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Anesthesiology
Decision date
Sep 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260226
Regulatory pathway
510(k) premarket notification
Product code
BZK
Decision code
SESE
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Spirometer, Monitoring (W/Wo Alarm).

Product code
BZK
FDA device class
2

FDA decision timeline

  1. K260226 received

    Application receipt date recorded by FDA.

  2. K260226 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Amptron Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Carlsbad, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records